• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量蛋白质组学和磷酸化蛋白质组学分析肺动脉高压大鼠模型肺组织。

Quantitative Proteomic and Phosphoproteomic Profiling of Lung Tissues from Pulmonary Arterial Hypertension Rat Model.

机构信息

College of Veterinary Medicine, Northwest A&F University, Xianyang 712100, China.

Life Science Research Core Service, Northwest A&F University, Xianyang 712100, China.

出版信息

Int J Mol Sci. 2023 Jun 1;24(11):9629. doi: 10.3390/ijms24119629.

DOI:10.3390/ijms24119629
PMID:37298580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10253736/
Abstract

Pulmonary arterial hypertension (PAH) is a rare but fatal disease characterized by elevated pulmonary vascular resistance and increased pressure in the distal pulmonary arteries. Systematic analysis of the proteins and pathways involved in the progression of PAH is crucial for understanding the underlying molecular mechanism. In this study, we performed tandem mass tags (TMT)-based relative quantitative proteomic profiling of lung tissues from rats treated with monocrotaline (MCT) for 1, 2, 3 and 4 weeks. A total of 6759 proteins were quantified, among which 2660 proteins exhibited significant changes (-value < 0.05, fold change < 0.83 or >1.2). Notably, these changes included several known PAH-related proteins, such as Retnla (resistin-like alpha) and arginase-1. Furthermore, the expression of potential PAH-related proteins, including Aurora kinase B and Cyclin-A2, was verified via Western blot analysis. In addition, we performed quantitative phosphoproteomic analysis on the lungs from MCT-induced PAH rats and identified 1412 upregulated phosphopeptides and 390 downregulated phosphopeptides. Pathway enrichment analysis revealed significant involvement of pathways such as complement and coagulation cascades and the signaling pathway of vascular smooth muscle contraction. Overall, this comprehensive analysis of proteins and phosphoproteins involved in the development and progression of PAH in lung tissues provides valuable insights for the development of potential diagnostic and treatment targets for PAH.

摘要

肺动脉高压(PAH)是一种罕见但致命的疾病,其特征是肺血管阻力升高和远端肺动脉压力增加。系统分析参与 PAH 进展的蛋白质和途径对于理解潜在的分子机制至关重要。在这项研究中,我们对用单环酸酯(MCT)处理 1、2、3 和 4 周的大鼠的肺组织进行了串联质量标签(TMT)相对定量蛋白质组学分析。共定量了 6759 种蛋白质,其中 2660 种蛋白质发生了显著变化(-值<0.05,倍数变化<0.83 或>1.2)。值得注意的是,这些变化包括几种已知的 PAH 相关蛋白,如 Retnla(抵抗素样α)和精氨酸酶-1。此外,通过 Western blot 分析验证了潜在的 PAH 相关蛋白,如 Aurora 激酶 B 和细胞周期蛋白 A2 的表达。此外,我们对 MCT 诱导的 PAH 大鼠的肺进行了定量磷酸蛋白质组学分析,鉴定出 1412 个上调的磷酸肽和 390 个下调的磷酸肽。途径富集分析显示,补体和凝血级联以及血管平滑肌收缩的信号通路等途径显著参与。总之,这项对肺组织中参与 PAH 发展和进展的蛋白质和磷酸蛋白质的全面分析为 PAH 的潜在诊断和治疗靶点的开发提供了有价值的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444f/10253736/0cdd258ed441/ijms-24-09629-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444f/10253736/823637ae1b3d/ijms-24-09629-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444f/10253736/a7f32cfa1729/ijms-24-09629-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444f/10253736/4f5448a52460/ijms-24-09629-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444f/10253736/0f2019f30976/ijms-24-09629-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444f/10253736/717975222e53/ijms-24-09629-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444f/10253736/0cdd258ed441/ijms-24-09629-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444f/10253736/823637ae1b3d/ijms-24-09629-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444f/10253736/a7f32cfa1729/ijms-24-09629-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444f/10253736/4f5448a52460/ijms-24-09629-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444f/10253736/0f2019f30976/ijms-24-09629-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444f/10253736/717975222e53/ijms-24-09629-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444f/10253736/0cdd258ed441/ijms-24-09629-g006.jpg

相似文献

1
Quantitative Proteomic and Phosphoproteomic Profiling of Lung Tissues from Pulmonary Arterial Hypertension Rat Model.定量蛋白质组学和磷酸化蛋白质组学分析肺动脉高压大鼠模型肺组织。
Int J Mol Sci. 2023 Jun 1;24(11):9629. doi: 10.3390/ijms24119629.
2
Proteomic and Phosphoproteomic Analysis of Right Ventricular Hypertrophy in the Pulmonary Hypertension Rat Model.右心室肥厚肺动脉高压大鼠模型的蛋白质组学和磷酸化蛋白质组学分析。
J Proteome Res. 2024 Jan 5;23(1):264-276. doi: 10.1021/acs.jproteome.3c00546. Epub 2023 Nov 28.
3
Curcumol suppresses endothelial-to-mesenchymal transition via inhibiting the AKT/GSK3β signaling pathway and alleviates pulmonary arterial hypertension in rats.莪术醇通过抑制AKT/GSK3β信号通路抑制内皮-间充质转化,并减轻大鼠肺动脉高压。
Eur J Pharmacol. 2023 Mar 15;943:175546. doi: 10.1016/j.ejphar.2023.175546. Epub 2023 Jan 25.
4
Integrative Proteomic and Phosphoproteomic Analyses of Hypoxia-Treated Pulmonary Artery Smooth Muscle Cells.缺氧处理的肺动脉平滑肌细胞的蛋白质组学和磷酸化蛋白质组学综合分析
Proteomes. 2022 Jun 28;10(3):23. doi: 10.3390/proteomes10030023.
5
Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.达格列净、西地那非及其联合治疗野百合碱诱导的肺动脉高压。
BMC Pulm Med. 2022 Apr 12;22(1):142. doi: 10.1186/s12890-022-01939-7.
6
Astragaloside IV improves pulmonary arterial hypertension by increasing the expression of CCN1 and activating the ERK1/2 pathway.黄芪甲苷通过增加 CCN1 的表达和激活 ERK1/2 通路来改善肺动脉高压。
J Cell Mol Med. 2023 Mar;27(5):622-633. doi: 10.1111/jcmm.17681. Epub 2023 Feb 10.
7
Fluoxetine inhibits monocrotaline-induced pulmonary arterial remodeling involved in inhibition of RhoA-Rho kinase and Akt signalling pathways in rats.氟西汀抑制野百合碱诱导的大鼠肺动脉重构,涉及 RhoA-Rho 激酶和 Akt 信号通路的抑制。
Can J Physiol Pharmacol. 2012 Nov;90(11):1506-15. doi: 10.1139/y2012-108. Epub 2012 Nov 8.
8
The zinc transporter ZIP12 regulates monocrotaline-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/ERK signaling pathways.锌转运蛋白 ZIP12 通过 AKT/ERK 信号通路调节野百合碱诱导的肺动脉平滑肌细胞增殖和迁移。
BMC Pulm Med. 2022 Mar 28;22(1):111. doi: 10.1186/s12890-022-01905-3.
9
Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.抑制 Shp2 可改善野百合碱诱导的大鼠肺动脉高压。
BMC Pulm Med. 2018 Aug 7;18(1):130. doi: 10.1186/s12890-018-0700-y.
10
LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.长链非编码 RNA-SMILR 通过靶向 miR-141 调节 RhoA/ROCK 信号通路,从而调节肺动脉高压中的血管重构。
Am J Physiol Heart Circ Physiol. 2020 Aug 1;319(2):H377-H391. doi: 10.1152/ajpheart.00717.2019. Epub 2020 Jun 19.

引用本文的文献

1
Transcriptomic profiling highlights cell proliferation in the progression of experimental pulmonary hypertension in rats.转录组谱分析突出了大鼠实验性肺动脉高压进展中的细胞增殖。
Sci Rep. 2024 Jun 18;14(1):14056. doi: 10.1038/s41598-024-64251-w.

本文引用的文献

1
Inhibition of Bruton's Tyrosine Kinase Alleviates Monocrotaline-Induced Pulmonary Arterial Hypertension by Modulating Macrophage Polarization.布鲁顿酪氨酸激酶抑制减轻单硝酸异山梨酯诱导的肺动脉高压通过调节巨噬细胞极化。
Oxid Med Cell Longev. 2022 Aug 29;2022:6526036. doi: 10.1155/2022/6526036. eCollection 2022.
2
iProX in 2021: connecting proteomics data sharing with big data.iProX 在 2021 年:将蛋白质组学数据共享与大数据连接起来。
Nucleic Acids Res. 2022 Jan 7;50(D1):D1522-D1527. doi: 10.1093/nar/gkab1081.
3
clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.
clusterProfiler 4.0:用于解释组学数据的通用富集工具。
Innovation (Camb). 2021 Jul 1;2(3):100141. doi: 10.1016/j.xinn.2021.100141. eCollection 2021 Aug 28.
4
Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension.联合使用 STAT3 抑制剂增强 SERCA2a 诱导的 BMPR2 表达并抑制肺动脉高压。
Int J Mol Sci. 2021 Aug 24;22(17):9105. doi: 10.3390/ijms22179105.
5
Microtubule associated protein 4 (MAP4) phosphorylation reduces cardiac microvascular density through NLRP3-related pyroptosis.微管相关蛋白4(MAP4)磷酸化通过NLRP3相关的细胞焦亡降低心脏微血管密度。
Cell Death Discov. 2021 Aug 12;7(1):213. doi: 10.1038/s41420-021-00606-w.
6
A proteogenomic portrait of lung squamous cell carcinoma.肺鳞状细胞癌的蛋白质基因组图谱。
Cell. 2021 Aug 5;184(16):4348-4371.e40. doi: 10.1016/j.cell.2021.07.016.
7
Profiling and Molecular Mechanism Analysis of Long Non-Coding RNAs and mRNAs in Pulmonary Arterial Hypertension Rat Models.肺动脉高压大鼠模型中长链非编码RNA和信使核糖核酸的分析及分子机制研究
Front Pharmacol. 2021 Jun 29;12:709816. doi: 10.3389/fphar.2021.709816. eCollection 2021.
8
Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.细胞因子、趋化因子与肺动脉高压中的炎症反应。
Adv Exp Med Biol. 2021;1303:275-303. doi: 10.1007/978-3-030-63046-1_15.
9
Integrative Omics to Characterize and Classify Pulmonary Vascular Disease.综合组学分析用于描述和分类肺血管疾病。
Clin Chest Med. 2021 Mar;42(1):195-205. doi: 10.1016/j.ccm.2020.10.001. Epub 2021 Jan 12.
10
Novel Advances in Modifying BMPR2 Signaling in PAH.肺动脉高压中修饰骨形态发生蛋白受体2信号传导的新进展
Genes (Basel). 2020 Dec 23;12(1):8. doi: 10.3390/genes12010008.